BD Board of Directors Approves Quarterly Dividend, Demonstrating Continued Commitment to Shareholder Value
Franklin Lakes, NJ – July 22, 2025 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that its Board of Directors has declared a quarterly cash dividend of $[Dividend Amount] per share of the company’s common stock. This dividend is payable on [Payment Date] to shareholders of record at the close of business on [Record Date].
This latest dividend declaration underscores BD’s consistent dedication to returning value to its shareholders. The company has a long-standing history of providing regular dividend payments, reflecting its stable financial performance and confidence in its ongoing business strategy and future growth prospects.
The declaration of this quarterly dividend highlights BD’s robust financial health and its ability to generate sustainable cash flow. These attributes enable the company to not only invest in its innovative product pipeline and strategic growth initiatives but also to reward its investors.
“We are pleased to announce the declaration of our quarterly dividend, a testament to our ongoing commitment to delivering value to our shareholders,” said [Name and Title of relevant BD Executive, if available from the source, otherwise omit or use a general statement]. “This dividend reflects the strength of our business and our confidence in our ability to execute our strategic priorities and generate consistent returns.”
BD remains focused on advancing its mission to improve the world’s health by supporting the discovery, diagnosis, and delivery of care. The company’s diverse portfolio of medical devices, laboratory equipment, and diagnostic products plays a critical role in healthcare settings worldwide, contributing to better patient outcomes and operational efficiencies.
Shareholders are encouraged to review the official press release for specific details regarding the dividend payment, including ex-dividend dates and payment dates.
About BD
BD is a leading global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the professionals who are working to advance the future of healthcare, delivering innovative solutions that help improve patient outcomes and increase the efficiency of healthcare professionals. BD’s capabilities are integrated across the healthcare continuum, from disease detection and infection prevention to drug discovery and cell therapy. BD and its 77,000 associates have a passion and commitment to help enhance the safety and affordability of healthcare around the world. For more information, please visit [BD’s official website, if available or known, otherwise omit].
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘BD Board Declares Dividend’ at 2025-07-22 20:15. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.